Group activity
- Veilleux created the group US FDA Expands Use Of Regeneron's Cholesterol Drug In Young Children"It was a very, very good year. All our activities did very well," CEO Torbjorn Tornqvist told Reuters on the sidelines of the Financial Times Commodities Global Summit, declining to give figures as the firm's results are still being...